Virpax Pharmaceuticals Inc. (VRPX)
Virpax Pharmaceuticals Statistics
Share Statistics
Virpax Pharmaceuticals has 1.24M shares outstanding. The number of shares has increased by 21.05% in one year.
Shares Outstanding | 1.24M |
Shares Change (YoY) | 21.05% |
Shares Change (QoQ) | 17.1% |
Owned by Institutions (%) | 0% |
Shares Floating | 1.22M |
Failed to Deliver (FTD) Shares | 134.87K |
FTD / Avg. Volume | 33.5% |
Short Selling Information
The latest short interest is 350.86K, so 2.36% of the outstanding shares have been sold short.
Short Interest | 350.86K |
Short % of Shares Out | 2.36% |
Short % of Float | 2.45% |
Short Ratio (days to cover) | 1.04 |
Valuation Ratios
The PE ratio is 0 and the forward PE ratio is -0.31. Virpax Pharmaceuticals's PEG ratio is 0.
PE Ratio | 0 |
Forward PE | -0.31 |
PS Ratio | 0 |
Forward PS | 0 |
PB Ratio | -0.04 |
P/FCF Ratio | 0 |
PEG Ratio | 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Virpax Pharmaceuticals.
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.63, with a Debt / Equity ratio of 0.
Current Ratio | 0.63 |
Quick Ratio | 0.63 |
Debt / Equity | 0 |
Debt / EBITDA | 0 |
Debt / FCF | 0 |
Interest Coverage | 116.43 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity | n/a |
Return on Assets | n/a |
Return on Invested Capital | n/a |
Revenue Per Employee | $0 |
Profits Per Employee | $-6.03B |
Employee Count | 2 |
Asset Turnover | 0 |
Inventory Turnover | n/a |
Taxes
Income Tax | 0 |
Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -99.31% in the last 52 weeks. The beta is 1.42, so Virpax Pharmaceuticals's price volatility has been higher than the market average.
Beta | 1.42 |
52-Week Price Change | -99.31% |
50-Day Moving Average | 5.13 |
200-Day Moving Average | 14.66 |
Relative Strength Index (RSI) | 13.49 |
Average Volume (20 Days) | 402.54K |
Income Statement
Revenue | n/a |
Gross Profit | 0 |
Operating Income | -12.08B |
Net Income | -12.07B |
EBITDA | -12.08B |
EBIT | -12.17B |
Earnings Per Share (EPS) | -2836.41 |
Balance Sheet
The company has 1.51M in cash and 0 in debt, giving a net cash position of 1.51M.
Cash & Cash Equivalents | 1.51M |
Total Debt | 0 |
Net Cash | 1.51M |
Retained Earnings | -71.61B |
Total Assets | 1.56M |
Working Capital | -913.76K |
Cash Flow
In the last 12 months, operating cash flow was -16.71B and capital expenditures 0, giving a free cash flow of -16.71B.
Operating Cash Flow | -16.71B |
Capital Expenditures | 0 |
Free Cash Flow | -16.71B |
FCF Per Share | -3928.38 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
VRPX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | n/a |
FCF Yield | n/a |
Analyst Forecast
Currently there are no analyst rating for VRPX.
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Stock Splits
The last stock split was on Mar 21, 2025. It was a backward split with a ratio of 1:25.
Last Split Date | Mar 21, 2025 |
Split Type | backward |
Split Ratio | 1:25 |
Scores
Altman Z-Score | -97.62 |
Piotroski F-Score | 0 |